Low-Dose or High-Dose Conditioning Followed by Peripheral Blood Stem Cell Transplant in Treating Patients With Myelodysplastic Syndrome or Acute Myelogenous Leukemia

ClinicalTrials.gov ID: NCT00322101

Public ClinicalTrials.gov record NCT00322101. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced May 16, 2026, 3:30 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multi-center Phase III Study Comparing Myeloablative to Nonmyeloablative Transplant Conditioning in Patients With Myelodysplastic Syndrome or Acute Myelogenous Leukemia

Study identification

NCT ID: NCT00322101
Recruitment status: Completed
Study type: Interventional
Phase: Phase 3
Lead sponsor: Fred Hutchinson Cancer Center; Other
Enrollment: 25 participants

Conditions and interventions

Conditions

Interventions

allogeneic hematopoietic stem cell transplantation Procedure
busulfan Drug
cyclophosphamide Drug
cyclosporine Drug
cytogenetic analysis Genetic
flow cytometry Other
fludarabine phosphate Drug
fluorescence in situ hybridization Genetic
laboratory biomarker analysis Other
methotrexate Drug
mycophenolate mofetil Drug
nonmyeloablative allogeneic hematopoietic stem cell transplantation Procedure
peripheral blood stem cell transplantation Procedure
pharmacological study Other
polymorphism analysis Genetic
tacrolimus Drug
total-body irradiation Radiation

Procedure · Drug · Genetic + 2 more

Eligibility (public fields only)

Age range: Up to 65 Years
Sex: All
Healthy volunteers: Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Dec 31, 2005
Primary completion: Mar 31, 2012
Completion: Sep 30, 2014
Last update posted: Oct 30, 2014

2006 – 2014

United States locations

U.S. sites: 7
U.S. states: 6
U.S. cities: 6

Facility	City	State	ZIP	Site status
HealthOne Presbyterian St. Lukes Medical Center	Denver	Colorado	—	—
Emory University	Altanta	Georgia	30322	—
Weill Cornell University	New York	New York	10021	—
University of Utah	Salt Lake City	Utah	84112	—
Veterans Administration Center-Seattle	Seattle	Washington	98108	—
Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium	Seattle	Washington	98109	—
Medical College Wisconsin	Milwaukee	Wisconsin	—	—

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT00322101, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Oct 30, 2014 · Synced May 16, 2026

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00322101 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →